+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mundipharma International Ltd. - logo

MundiPharma is an Irish owned company established in 1973. There break through drug was sustained release morphine (MST® Continus® tablets). This product was seen as a major advantage in handling cancer treatment pain. MundiPharma focus on three main areas: analgesic, oncology and respiratory therapy areas. They are constantly innovating new products to help people with debilitating diseases. Mundi Pharma is part of a worldwide network of independent associated pharmaceutical companies.

CINV Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

CINV Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 121 Pages
  • Global
From
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H1 2020 - Product Thumbnail Image

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H1 2020

  • Drug Pipelines
  • April 2020
  • 53 Pages
  • Global
From
Trauma Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Trauma Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • July 2020
  • 288 Pages
  • Global
From
Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 386 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Loading Indicator